Author:
Drummond M W,Lush C J,Vickers M A,Reid F M,Kaeda J,Holyoake T L
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference8 articles.
1. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Lebeau MM & Rowley JD . Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 76: 1765–1772.
2. Melo J . The diversity of Bcr-Abl fusion proteins and their relationship to leukaemia phenotype. Blood 1996; 88: 2375–2384.
3. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S & Sawyers CL . Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037.
4. Verhoef G, Meeus P, Stul M, Mecucci C, Cassiman J, Van Den Berghe H & Boogaerts M . Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Cancer Genet Cytogenet 1992; 59: 161–166.
5. Jaffe ES, Harris NL, Stein H & Vardiman JW . WHO classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: Kleihues P, Sobin LH (eds). WHO Classification of Tumours, 1st edn. IARC Press: Lyon, 2001, pp 63–73.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献